Search
InsiderInsights.com

Belldegrun Arie (1296549)

Belldegrun Arie has been a registered insider at 5 firms since 2004. As a Director at UroGen Pharma, Belldegrun Arie last made a transaction on 9/14/2022. As a Director at Allogene Therapeutics, Inc., Belldegrun Arie last made a transaction on 1/12/2022. As a Director at Kronos Bio, Inc., Belldegrun Arie last made a transaction on 10/14/2020. As Chairman at Kite Pharma, Belldegrun Arie last made a transaction on 9/25/2017. As a Director at Cougar Biotechnology, Inc., Belldegrun Arie last made a transaction on 2/20/2008.

(URGN)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 0% -57% -57% 10 1 Year 2 0% -- -- --
4 50% 1% 11% 102 9 Month 4 0% -- -- --
4 25% -3% -9% 67 6 Month 4 0% -- -- --
4 25% -7% -10% 29 3 Month 4 0% -- -- --
4 75% 10% 6% 37 1 Month 4 0% -- -- --
4 75% 2% 3% 19 1 Week 4 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:15 PM EST Latest Transaction Date: 9/14/2022
Average days between Transaction and Entered Dates: 9

(ALLO)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
4 25% -38% -46% 81 1 Year 4 0% -- -- --
4 25% -24% -24% 74 9 Month 4 0% -- -- --
4 25% -13% -14% 28 6 Month 4 0% -- -- --
4 25% -12% -12% 53 3 Month 4 0% -- -- --
4 50% -2% 1% 36 1 Month 4 0% -- -- --
4 25% -7% -7% 17 1 Week 4 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:15 PM EST Latest Transaction Date: 1/12/2022
Average days between Transaction and Entered Dates: 2

(KRON)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% -48% -- -- 1 Year 1 0% -- -- --
1 0% -36% -- -- 9 Month 1 0% -- -- --
1 0% -33% -- -- 6 Month 1 0% -- -- --
1 0% -2% -- -- 3 Month 1 0% -- -- --
1 0% -13% -- -- 1 Month 1 0% -- -- --
1 100% 1% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:15 PM EST Latest Transaction Date: 10/14/2020
Average days between Transaction and Entered Dates: 2

Kite Pharma, Inc. (KITE)

Titles: CB,PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
1 100% 67% -- -- 3 Month 1 0% -- -- --
1 100% 20% -- -- 1 Month 1 0% -- -- --
1 100% 5% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
1 0% 289% -- -- 9 Month 1 0% -- -- --
1 0% 104% -- -- 6 Month 1 0% -- -- --
1 0% 62% -- -- 3 Month 1 0% -- -- --
1 0% 2% -- -- 1 Month 1 0% -- -- --
2 50% -1% -1% 2 1 Week 2 0% -- -- --
Scorecards Updated 6/14/2023 12:15 PM EST Latest Transaction Date: 9/25/2017
Average days between Transaction and Entered Dates: 2

Cougar Biotechnology, Inc. (CGRB)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
3 33% -2% -10% 35 1 Year 3 0% -- -- --
3 33% -9% -21% 49 9 Month 3 0% -- -- --
3 67% 17% 27% 37 6 Month 3 0% -- -- --
3 33% -13% -1% 43 3 Month 3 0% -- -- --
3 33% -8% -7% 19 1 Month 3 0% -- -- --
3 67% -8% 0% 43 1 Week 3 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:15 PM EST Latest Transaction Date: 2/20/2008
Average days between Transaction and Entered Dates: 6
© 2024 InsiderInsights.com